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Booster HBV vaccination; is it really necessary?  
 
 
To the editor, 
I read with interest the published article by El-
Sayed et al.1 in your journal recently. Soon after 
introducing recombinant hepatitis B virus (HBV) 
vaccine, universal neonatal vaccination became the 
cornerstone of the preventive measures for control 
of HBV infection2. By 2006 more than 177 out of 
193 member states of the World Health 
Organization (WHO) introduced HBV vaccination 
in their national infant immunization programs2. 
The measurement of post vaccination serum level 
of anti-hepatitis B surface antibody (anti-HBs) is 
the only simple test available to predict the waning 
of protection and help plan for the administration of 
a booster dose especially in high risk groups3. A 
level of 10 IU/L of anti HBsAb is usually 
considered as a protective level against future 
infections. The reported rate of persistent protective 
level of anti HBsAb titers varied from 33% up to 
79%, at least 5 years after vaccination2.  
It is obvious that the percentage of negative anti 
HBsAb after 10 years would be more than that in 5 
years after HBV vaccination. The main question is 
about the rate of HBs Ag seroconversion in this 
group, which is confirmed to be decreasing 
significantly in all studies. Furthermore, the more 
coverage of HBV vaccination especially in rural 
areas is a key point in this achievement. Fortunately 
the anti HBsAb after vaccination was significantly 
high in most children especially in group A after 5 
years of HBV vaccination. 
Another point is that more females were 
included in children over 10 years old, which limits 
the conclusion in table 3 regarding higher level of 
HBsAb in males. Furthermore, most studies have 
found that there were no gender differences in the 
immunological response to HBV vaccine3. And 
finally I would like to emphasize that due to an 
increase in anti HBsAb level in most of the children 
after receiving the booster of HBV vaccine, I agree 
with the authors that there is no need for HBV 
vaccination as booster in children after completing 
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